文献速递神经核医学肿瘤 PET/CT

局灶性病变性癫痫中PET代谢与SEEG致痫性的关系

Relationship between PET metabolism and SEEG epileptogenicity in focal lesional epilepsy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-05-20

本研究纳入38例皮质发育畸形(MCD)所致药物难治性癫痫患者,比较18F-FDG PET代谢与立体定向脑电图(SEEG)定义的致痫区(EZ)的关系。结果显示PET低代谢从非累及区到传播区、致痫区及病变区呈梯度变化(p<0.001),PET界定EZ的AUC为0.82,低代谢范围超出SEEG采样范围与术后预后较差相关(p=0.024)。

要点

  • MCD患者PET低代谢呈梯度:非累及区→传播区→致痫区→病变区(p<0.001)。
  • PET界定EZ的AUC为0.82,即使低代谢不局限于EZ。
  • 低代谢范围超出SEEG采样范围与术后预后较差相关(p=0.024)。

核心结论

  • 18F-FDG-PET在MCD患者中界定EZ具有良好准确性,即使低代谢不局限于EZ。
  • 低代谢扩展与术后预后不良相关。

研究设计与样本

  • 研究纳入38例MCD所致药物难治性癫痫患者,均行18F-FDG PET与SEEG检查。
  • 基于MRI和SEEG在个体水平划分4个不同区域:病变区、致痫非病变区、传播区、非累及区。
  • 将每例患者的PET代谢与健康对照人群比较。

主要发现

  • PET低代谢从非累及区到传播区、再到致痫区和病变区呈梯度变化(p<0.001)。
  • PET界定EZ的ROC曲线AUC=0.82。
  • PET低代谢扩展超出SEEG采样范围与术后预后较差相关(p=0.024)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to evaluate the performance of 18F-FDG PET for distinguishing the epileptogenic zone (EZ) from propagation and non-involved zones at brain area level, as defined using stereo-EEG (SEEG), in patients with pharmacoresistant epilepsy due to malformations of cortical development (MCD). Additionally, we seek to determine the relationship between 18F-FDG-PET data and post-surgical seizure outcome. METHODS: Thirty-eight patients with MCD were explored with 18F-FDG PET and SEEG. We compared PET metabolism of each patient to a control population of healthy subjects. Based on MRI and SEEG, we separated 4 distinct zones at individual level: lesional, epileptogenic non-lesional, propagation, and non-involved. Then, we analysed (1) difference of PET metabolism within these four distinct zones; (2) performance of PET in defining the EZ within the SEEG-sampled areas; and (3) relation between extension of PET hypometabolism and post-surgical seizure outcome. RESULTS: We found (1) a gradient of PET hypometabolism from non-involved to propagation, then to epileptogenic and lesional zones (p < 0.001); (2) good performance of PET in defining the EZ (AUC of ROC curve = 0.82); (3) poorer post-surgical prognosis associated with PET hypometabolism extension beyond SEEG sampling (p = 0.024). CONCLUSION: 18F-FDG-PET has good accuracy in determining EZ in patients with MCD even if the hypometabolism is not limited to the EZ. Furthermore, hypometabolic extension is unfavourably associated with post-surgical prognosis.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Lagarde S, Boucekine M, McGonigal A, et al. Relationship between PET metabolism and SEEG epileptogenicity in focal lesional epilepsy. Eur J Nucl Med Mol Imaging. 2020. PMID: 32430581. doi:10.1007/s00259-020-04791-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。